Skip to main content
. 2018 Jul 6;9(52):29944–29956. doi: 10.18632/oncotarget.25714

Table 7. Comorbidities.

CLL; n (% of all CLL patients) FL; n (% of all FL patients)
Atrial fibrillation 1 (12,5) 1 (14,3)
Coronary artery disease 2 (25) 0
Diabetes mellitus type II 2 (25) 0
Hematologic comorbidities 0 1 previous DLBCL (14,3)
Hepatitis C 0 1 eradicated Hepatitis C (14,3)

Abbreviations: DLBCL: Diffuse Large B-cell Lymphoma.